Schetelig, J., Thiede, C., Bornhauser, M., Schwerdtfeger, R., Kiehl, M., Beyer, J., Kroger, N., Hensel, M., Scheffold, C., Ho, A.D., Kienast, J., Neubauer, A., Zander, A.R., Fauser, A.A., Ehninger, G. & Siegert, W. (2002) Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia. Ann Hematol, 81 Suppl 2, S47-48.

Thiede, C., Lutterbeck, K., Oelschlagel, U., Kiehl, M., Steudel, C., Platzbecker, U., Brendel, C., Fauser, A.A., Neubauer, A., Ehninger, G. & Bornhauser, M. (2002) Detection of relapse by sequential monitoring of chimerism in circulating CD34+ cells. Ann Hematol, 81 Suppl 2, S27-28.

Reuter, U., Roesler, J., Thiede, C., Schulz, A., Classen, C.F., Oelschlagel, U., Debatin, K.M. & Friedrich, W. (2002) Correction of complete interferon-gamma receptor 1 deficiency by bone marrow transplantation. Blood, 100, 4234-4235.

Kreuzer, K.A., Schmidt, C.A., Schetelig, J., Held, T.K., Thiede, C., Ehninger, G. & Siegert, W. (2002) Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia. Eur J Haematol, 69, 7-10.

Illmer, T., Schuler, U.S., Thiede, C., Schwarz, U.I., Kim, R.B., Gotthard, S., Freund, D., Schakel, U., Ehninger, G. & Schaich, M. (2002) MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res, 62, 4955-4962.

Thiede, C., Steudel, C., Mohr, B., Schaich, M., Schakel, U., Platzbecker, U., Wermke, M., Bornhauser, M., Ritter, M., Neubauer, A., Ehninger, G. & Illmer, T. (2002) Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood, 99, 4326-4335.

Liu, H., Ye, H., Ruskone-Fourmestraux, A., De Jong, D., Pileri, S., Thiede, C., Lavergne, A., Boot, H., Caletti, G., Wundisch, T., Molina, T., Taal, B.G., Elena, S., Thomas, T., Zinzani, P.L., Neubauer, A., Stolte, M., Hamoudi, R.A., Dogan, A., Isaacson, P.G. & Du, M.Q. (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 122, 1286-1294.

Stolte, M., Bayerdorffer, E., Morgner, A., Alpen, B., Wundisch, T., Thiede, C. & Neubauer, A. (2002) Helicobacter and gastric MALT lymphoma. Gut, 50 Suppl 3, III19-24.

Schetelig, J., Kroger, N., Held, T.K., Thiede, C., Krusch, A., Zabelina, T., Dubiel, M., Rick, O., Bornhauser, M., Ehninger, G., Zander, A.R. & Siegert, W. (2002) Allogeneic transplantation after reduced conditioning in high risk patients is complicated by a high incidence of acute and chronic graft-versus-host disease. Haematologica, 87, 299-305.


AgenDix -
Applied Genetic Diagnostics -
Gesellschaft für angewandte molekulare Diagnostik mbH

Fiedlerstr. 36
01307 Dresden

Tel: 0351 456 975 0
Fax: 0351 456 975 22

Veröffentlichungen auf PubMed